# Changes in Exhaled 13CO2/12CO2 Breath Delta Value as an Early Indicator of Infection in ICU Patients

> **NCT02327130** · NA · COMPLETED · sponsor: **Isomark, LLC** · enrollment: 32 (actual)

## Conditions studied

- Sepsis

## Interventions

- **DEVICE:** Isomark Canary™

## Key facts

- **NCT ID:** NCT02327130
- **Lead sponsor:** Isomark, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2019-01-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02327130

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02327130, "Changes in Exhaled 13CO2/12CO2 Breath Delta Value as an Early Indicator of Infection in ICU Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02327130. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*